Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    16196117 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
Condition: Uveitis
Interventions: Device: Optical Coherence Tomography (OCT);   Other: Eye Exam
2 Recruiting Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Condition: Cataract
Interventions: Drug: nepafenac 0.3%;   Drug: ketorolac
3 Recruiting Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
Conditions: Uveitis;   Non-Infectious Uveitis
Intervention: Drug: Adalimumab
4 Recruiting PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Conditions: Macular Edema;   Uveitis
Interventions: Drug: Periocular triamcinolone 40 mg;   Drug: Intravitreal triamcinolone 4 mg;   Drug: Dexamethasone intravitreal implant
5 Recruiting Methotrexate and Mycophenolate Mofetil for UVEITIS
Condition: Uveitis
Interventions: Drug: Mycophenolate mofetil;   Drug: Methotrexate;   Drug: Prednisone
6 Active, not recruiting Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Uveitis, Intermediate
Interventions: Drug: Myfortic;   Drug: Decortin
7 Completed Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Condition: Anterior Uveitis
Intervention: Drug: Sirolimus

Indicates status has not been verified in more than two years